Evaluating the cellular components of blood allows detection of numerous medical conditions. The complete blood count (CBC) indicates variations in the numbers and appearance of red blood cells, white blood cells), and platelets from their predictable, ‘normal’ state can indicate the presence of disease.
According to a recent report from Markets and Markets, the global cell counting market is expected to reach $8.6 Billion by the end of 2020, growing at a CAGR of 6.5% to 7.0% during the forecast period 2015 to 2020. Factors driving this market include:
- Rising incidence of cancer and infectious diseases
- Increasing expenditure on R&D and healthcare by government and private organizations
- Growth in stem cell and cancer research
End users of cell counting systems include hospitals and diagnostic laboratories, research institutions, pharmaceutical and biotechnology companies. However, the report points out that there are several factors inhibiting the growth of the market: high prices of advanced cell counting systems and reluctance among researchers to use advanced cell counting techniques, and shortage of knowledgeable and skilled professionals in clinical laboratories.
While the instruments market is divided into four major segments – spectrophotometers, flow cytometers, hematology analyzers, and cell counters, the consumables segment is subdivided into reagents, assay kits, microplates, accessories, and other consumables. In 2014, spectrophotometers accounted for the largest share of the market.
The key market players listed are Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.). These manufacturers accounted for around 65% to 70% of the global market share in 2014.
The report also says that factors such as rising aging population, increasing research collaboration, and increasing R&D and healthcare expenditure have made the Asia-Pacific region the fastest-growing market for the cell counting instruments and consumables.